Sandu Pharmaceuticals Ltd Quarterly Results
Q4 FY24-25 Results Summary
Revenue
The revenue stands at ₹14.07 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 20.51 per cent from ₹17.70 crore. This corresponds to a year-on-year *(YoY) decline of 19.28 per cent.
Operating Profit
Operating Profit stands at ₹0.45 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 50.55 per cent from ₹0.91 crore. This corresponds to a year-on-year *(YoY) decline of 11.76 per cent.
PBDT
PBDT stands at ₹0.49 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 46.15 per cent from ₹0.91 crore. This corresponds to a year-on-year *(YoY) decline of 5.77 per cent.
Profit Before Tax
Profit Before Tax stands at ₹0.34 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 54.05 per cent from ₹0.74 crore. This corresponds to a year-on-year *(YoY) decline of 10.53 per cent.
Net Profit
Net Profit stands at ₹0.33 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 34.00 per cent from ₹0.50 crore. This represents a 57.14 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Sandu Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Sandu Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Sandu Pharmaceuticals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Sandu Pharmaceuticals Ltd Financial Reports
Sandu Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Sandu Pharma. | 2.86% | 0.53% | -4.47% | -8.12% | 18.02% | -19.85% |
| Vista Pharma. | 1.08% | -9.77% | -9.64% | -17.07% | -8.38% | -37.58% |
| Parmax Pharma | -2.00% | 3.97% | 34.19% | 228.95% | 208.01% | 181.19% |
| Goldline Pharmaceutical | 7.73% | 5.95% | -4.47% | -28.84% | -28.84% | -28.84% |
| Roopa Industries | -6.35% | -4.02% | -4.67% | -19.07% | 7.84% | -13.26% |
| Bacil Pharma | -4.96% | -18.48% | -41.69% | -58.71% | -41.61% | -38.82% |
| Panjon | -0.73% | -2.11% | -1.45% | -25.16% | -19.83% | -3.02% |
Company Info
Company Information
Chairman & Managing Director : Balaram Vishwanathan
Non-Exec & Non-Independent Dir : Shashank B Sandu
Non-Exec & Non-Independent Dir : Jayshree Sandu
Independent Non Exe. Director : Ajit Rajaram Kantak
Independent Non Exe. Director : Vijay Kottapalli
Company Sec. & Compli. Officer : Pratika Mhambray
Additional Director : Neeti Madan Kapre